Page last updated: 2024-10-26

etanidazole and Cerebral Infarction

etanidazole has been researched along with Cerebral Infarction in 1 studies

Etanidazole: A nitroimidazole that sensitizes hypoxic tumor cells that are normally resistant to radiation therapy.
etanidazole : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of (2-nitro-1H-imidazol-1-yl)acetic acid with the amino group of ethanolamine. Used as a radiosensitising agent for hypoxic tumour cells.

Cerebral Infarction: The formation of an area of NECROSIS in the CEREBRUM caused by an insufficiency of arterial or venous blood flow. Infarcts of the cerebrum are generally classified by hemisphere (i.e., left vs. right), lobe (e.g., frontal lobe infarction), arterial distribution (e.g., INFARCTION, ANTERIOR CEREBRAL ARTERY), and etiology (e.g., embolic infarction).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
MacManus, JP1
Koch, CJ1
Jian, M1
Walker, T1
Zurakowski, B1

Other Studies

1 other study available for etanidazole and Cerebral Infarction

ArticleYear
Decreased brain infarct following focal ischemia in mice lacking the transcription factor E2F1.
    Neuroreport, 1999, Sep-09, Volume: 10, Issue:13

    Topics: Animals; Brain Ischemia; Carrier Proteins; Cell Cycle Proteins; Cerebral Infarction; Cerebrovascular

1999